Stock Report

Download full stock data and analysis for free Last Updated: 28-Aug-2026

Stock Rating

Is this stock worth it? Our ratings reveal the truth.

Wealth Insight New Issue

This month’s issue could change how you invest, read now.

Recently Viewed

Clear All

Palatin Technologies (PTN) Peer Comparison

Stock Card factsheet share-fund-plan-icon

$10.56

up-down-arrow $-12.44 (-54.09%)

As on 28-Aug-2026 10:28EDT

Market cap

info icon

$17 Mln

Revenue (TTM)

info icon

$13 Mln

P/E Ratio

info icon

88.1

P/B Ratio

info icon

1.7

Div. Yield

info icon

0 %

Edit peer-selector-edit
Palatin Technologies (PTN) Medpace Holdings (MEDP) Ascendis Pharma A/S - ADR Exelixis (EXEL) Arrowhead Pharmaceuticals (ARWR)
Market cap ($ Mln)
 17 17,326 16,614 13,400 12,305
Revenue ($ Mln)
 13 2,782 1,054 2,436 670
Net Profit ($ Mln)
 -6.25 491.50 755.85 860.62 -319.95
Net Margin (%)
 -48.50 17.67 71.69 35.33 -47.79
RoE (%)
 -113.74 110.09 -- 42.98 -71.14
Price to Earnings
 88.09 36.49 19.38 17.01 --
Price-To-Book
 1.71 39.43 10.05 7.27 26.44

Income Statement ($ Mln)

Palatin Technologies (PTN) Medpace Holdings (MEDP) Ascendis Pharma A/S - ADR Exelixis (EXEL) Arrowhead Pharmaceuticals (ARWR)
Operating Revenue arrow
12.88 2,782.29 1,054.37 2,435.92 669.50
Cost of Revenue arrow
0.08 1,982.07 103.47 85.67 19.14
Gross Profit arrow
-0.26 760.62 588.53 2,236.43 829.45
Operating Expenses arrow
19.39 216.81 841.45 1,378.74 895.93
Operating Profit (EBIT) arrow
-6.52 583.40 109.45 971.51 -226.44
Other Income arrow
0.00 0.00 0.00 0.00 0.00
Profit before Tax arrow
-6.25 598.92 101.11 1,035.47 -252.08
Provision for Tax arrow
0.00 107.42 -654.74 174.84 20.05
Profit after Tax (Net Income) arrow
-6.25 491.50 755.85 860.62 -319.95
Minority Interest arrow
0.00 0.00 0.00 0.00 -47.83
Consolidated Profit arrow
-4.82 0.00 0.00 0.00 0.00

Liabilities ($ Mln)

Palatin Technologies (PTN) Medpace Holdings (MEDP) Ascendis Pharma A/S - ADR Exelixis (EXEL) Arrowhead Pharmaceuticals (ARWR)
Shareholder's Funds arrow
10.59 433.86 1,435.90 1,843.76 465.53
Minority Interest arrow
0.00 0.00 0.00 0.00 -47.83
Non-Current Liabilities arrow
0.10 187.89 384.48 288.55 1,362.63
Current Liabilities arrow
2.54 1,435.43 464.70 361.93 283.35
Total Liabilities arrow
3.27 1,975.47 1,302.02 2,844.42 1,385.30

Assets ($ Mln)

Palatin Technologies (PTN) Medpace Holdings (MEDP) Ascendis Pharma A/S - ADR Exelixis (EXEL) Arrowhead Pharmaceuticals (ARWR)
Non-Current Assets arrow
0.44 1,006.90 895.24 1,243.41 440.60
Current Assets arrow
12.79 1,050.29 1,389.84 1,250.82 1,671.41
Total Assets arrow
3.27 1,975.47 1,302.02 2,844.42 1,385.30
Total Debt* arrow
0.29 120.10 449.89 165.93 864.07
Net Current Assets arrow
10.25 -385.14 0.00 888.90 1,388.07

Cashflow ($ Mln)

Palatin Technologies (PTN) Medpace Holdings (MEDP) Ascendis Pharma A/S - ADR Exelixis (EXEL) Arrowhead Pharmaceuticals (ARWR)
Cash From Operating Activities arrow
-21.31 713.22 51.77 884.27 179.55
Cash Flow from Investing Activities arrow
3.13 -31.14 -8.15 350.44 -129.29
Cash from Financing Activities arrow
11.21 -860.39 34.89 -969.59 74.01
Net Cash Inflow / Outflow arrow
-- -- -- -- --

Ratios

Profitability Ratios

 Palatin Technologies (PTN) Medpace Holdings (MEDP) Ascendis Pharma A/S - ADR Exelixis (EXEL) Arrowhead Pharmaceuticals (ARWR)
ROCE (%) arrow
837.23 53.56 -30.01 32.82 -0.17
ROE (%) arrow
-113.74 110.09 163.18 42.98 -71.14
ROA (%) arrow
-42.31 15.64 26.53 29.32 -16.12
EBIT Margin (%) arrow
-48.45 21.13 5.73 31.04 -0.77
Net Margin (%) arrow
-48.50 17.67 71.69 35.33 -47.79
Cash Profit Margin (%) arrow
0.00 0.00 0.00 0.00 0.00

Growth Ratios

 Palatin Technologies (PTN) Medpace Holdings (MEDP) Ascendis Pharma A/S - ADR Exelixis (EXEL) Arrowhead Pharmaceuticals (ARWR)
Revenue Growth (%) arrow
3,581.22 24.67 114.85 9.23 12.22
EBIT Growth (%) arrow
73.23 18.70 136.39 -3.99 93.17
Net Profit Growth (%) arrow
73.21 17.50 378.76 42.89 -115.58
EPS Growth (%) arrow
-64.15 26.84 353.27 50.42 -73.87
Book Value Growth (%) arrow
1,249.99 164.02 816.12 -0.70 -13.57

Valuation Ratios

 Palatin Technologies (PTN) Medpace Holdings (MEDP) Ascendis Pharma A/S - ADR Exelixis (EXEL) Arrowhead Pharmaceuticals (ARWR)
Price / Earnings arrow
-0.03 36.06 -59.76 15.79 -2,869.63
Price / Book Value arrow
-0.09 35.44 -80.42 5.72 10.04
Dividend Yield (%) arrow
-- -- -- -- --
EV/EBITDA arrow
0.12 28.08 -121.54 12.44 25.04
Market Cap ($ Cr) arrow
-- -- -- -- --

Solvency Ratios

 Palatin Technologies (PTN) Medpace Holdings (MEDP) Ascendis Pharma A/S - ADR Exelixis (EXEL) Arrowhead Pharmaceuticals (ARWR)
Debt to Equity arrow
0.00 0.00 0.00 0.00 1.77
Short term debt to equity ratio arrow
0.02 0.00 0.05 0.00 0.09
Current Ratio arrow
5.04 0.73 2.99 3.46 5.90
Quick Ratio arrow
5.04 0.73 2.32 3.38 5.90
Interest Coverage arrow
-860.35 -- 1.62 -- -1.72

Operating Efficiency Ratios

 Palatin Technologies (PTN) Medpace Holdings (MEDP) Ascendis Pharma A/S - ADR Exelixis (EXEL) Arrowhead Pharmaceuticals (ARWR)
Debtors to sales (%) arrow
16.82 15.88 21.25 13.74 1.28
Asset Turnover arrow
0.87 0.89 0.37 0.83 0.34
Receivable days arrow
-- 50.42 85.52 43.48 1.50
Inventory Days arrow
0.00 -- 1,056.70 96.17 --
Payable days arrow
7,829.81 6.26 331.01 147.97 221.81
Cash Conversion Cycle arrow
-- -- 811.21 -8.32 --
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
loading...
loading...